Management of Iron Deficiency with Normal Hemoglobin
All patients with confirmed iron deficiency should receive iron supplementation to replenish body stores, even when hemoglobin is normal. 1
Diagnostic Confirmation
Before initiating treatment, confirm iron deficiency with:
- **Serum ferritin <30 µg/L** for healthy males and females aged >15 years 2
- MCV <76 fL (if available) 1
- Exclude acute phase reaction by checking C-reactive protein, as inflammation falsely elevates ferritin despite true iron deficiency 2
For younger patients, use lower ferritin cut-offs: 15 µg/L for children 6-12 years and 20 µg/L for adolescents 12-15 years 2
Investigation for Underlying Cause
The extent of investigation depends on patient demographics and risk factors:
Patients >45 Years
- Upper GI endoscopy with small bowel biopsy AND colonoscopy or barium enema should be performed in 90% of cases unless an obvious cause is identified 1
- This aggressive approach is warranted due to increasing incidence of significant pathology with age 1
Patients <45 Years
- With upper GI symptoms: Perform endoscopy and small bowel biopsy 1
- Without upper GI symptoms: Check antiendomysial antibody (and IgA levels to exclude IgA deficiency) to screen for celiac disease 1
- Colonic investigation only if specific indications present 1
Premenopausal Women
- Iron deficiency occurs in 5-10% of menstruating women 1
- Menstrual loss, menorrhagia, pregnancy, and breastfeeding are usually responsible 1
- Consider pictorial blood loss assessment charts (80% sensitivity/specificity for menorrhagia) 1
Treatment Protocol
First-Line: Oral Iron Supplementation
Ferrous sulfate 200 mg three times daily is the simplest and most cost-effective option 1
Alternative oral preparations with equivalent efficacy:
Add ascorbic acid if response is poor, as it enhances iron absorption 1
Duration of Treatment
Continue iron supplementation for three months after correction of laboratory values to replenish iron stores 1
Even with normal hemoglobin at baseline, the goal is to normalize ferritin and prevent progression to anemia 1
Monitoring Response
- Recheck hemoglobin, MCV, and ferritin at 8-10 weeks 2
- Hemoglobin should rise by 2 g/dL after 3-4 weeks if anemia develops during follow-up 1
- Failure to respond suggests poor compliance, misdiagnosis, continued blood loss, or malabsorption 1
Long-Term Follow-Up
- Monitor hemoglobin and red cell indices every 3 months for one year, then annually 1
- Repeat oral iron if hemoglobin or MCV falls below normal (check ferritin in doubtful cases) 1
- Patients with repeatedly low ferritin benefit from intermittent oral substitution and monitoring every 6-12 months 2
Parenteral Iron Therapy
Reserve intravenous iron for specific circumstances only:
- Intolerance to at least two oral preparations 1
- Non-compliance with oral therapy 1
- Concomitant disease requiring urgent treatment 2
- Repeated failure of oral therapy 2
Ferric carboxymaltose (Injectafer) allows delivery of up to 1,000 mg iron in a single 15-minute infusion 3, 4
For patients ≥50 kg: 750 mg IV in two doses separated by at least 7 days (total 1,500 mg per course) 3
Critical Caveats
- Do NOT administer preventative iron when stores are normal - this is inefficient, causes side effects, and may be harmful 2
- Faecal occult blood testing has no benefit - it is insensitive and non-specific 1
- Gastrointestinal side effects are the primary cause of poor compliance with oral iron; using preparations with 28-50 mg elemental iron may improve tolerance 2
- Long-term daily supplementation with normal or high ferritin is potentially harmful and not recommended 2